An HPLC method for the determination of lisinopril in human plasma and urine with fluorescence detection
Authors:
- Olcay SagirliOSOlcay Sagirli
- Lale ErsoyLELale Ersoy
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 809 (1) , 159-165
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A new spectrofluorimetric method for the determination of lisinopril in tabletsIl Farmaco, 2003
- Spectrophotometric and HPTLC-densitometric determination of lisinopril and hydrochlorothiazide in binary mixturesJournal of Pharmaceutical and Biomedical Analysis, 2001
- Spectrophotometric, septrofluorimetric and LC determination of lisinoprilJournal of Pharmaceutical and Biomedical Analysis, 2001
- Spectrophotometric and spectrofluorometric methods for the assay of lisinopril in single and multicomponent pharmaceutical dosage formsJournal of Pharmaceutical and Biomedical Analysis, 1999
- An improved method for the measurement of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometryRapid Communications in Mass Spectrometry, 1999
- Time-resolved fluoroimmunoassay for the determination of lisinopril and enalaprilat in human serumJournal of Pharmaceutical and Biomedical Analysis, 1996
- Determination of the angiotensin-converting enzyme inhibitor lisinopril in urine using solid-phase extraction and reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Pharmacokinetics of lisinopril (IV/PO) in healthy volunteersBiopharmaceutics & Drug Disposition, 1989
- LisinoprilDrugs, 1988
- Radioimmunoassay for the Quantitation of Lisinopril and EnalaprilatJournal of Pharmaceutical Sciences, 1986